topic covers development and market status of drugs, devices and overall clinical management of obesity; excludes coverage of over the counter, consumer-oriented weight loss products
Looking at the course of developments — in the healthcare reform "debate" (as it were) and medical technology — it is not a huge leap of judgment to make the following predictions for the ups and downs of healthcare overall and for specific medical technologies.
Predictions for the healthcare market
A healthcare reform package will pass this [...]
In cardiovascular and spine surgery, multi-billion dollar markets were created from entirely new procedures between 1980 and 2000, with subsequent segmentation in later years particularly as new minimally invasive procedures were developed towards the end of the 20th century. In the cardiovascular arena, the development of new procedures for angioplasty and bypasses in the late [...]
Below is a sampling of recently identified medical technology startups, identified in 2009 (drawn from the Medtech Startups Database).
Company
Product/technology
QFX Technologies, Inc.
External fixation for leg bone fractures.
Axis Surgical Technologies, Inc.
Devices for minimally invasive spine surgery
NuOrtho Surgical, Inc.
Radiofrequency preservation of tissues during orthopedic surgery
Selecta Biosciences, Inc.
Nanoparticle-based immunomodulatory drugs.
EndoMetabolic Solutions, Inc.
Pharmaceutical preparations for treatment of obesity.
AVIDAL Vascular GmbH
Drug-eluting [...]
The world market for energy-based devices was well in excess of $25 billion in 2008. This represents almost 14% of the total medical device market; however, the share varies from country to country, since ablation therapy is high-technology and fairly high-cost; in poorer economies low-cost medical products such as syringes and consumables account for a [...]
Below is a list of pending or recent reports from MedMarket Diligence.
COMING SOON
Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017
$4,250
(print or PDF; add $200 to receive both)
[...]
Fibrin and other sealant products have been approved and used outside the United States for many years and their use has created strong awareness of their surgical and economic benefits in Europe, Latin America and Asia. As a result, many such products have been marketed in these regions for up to 20 years and have [...]
Obesity puts a burden on so many aspects of life that the socioeconomic cost is almost inevitably enormous—as well as challenging to quantify. At the individual level, there is the lower quality of life, days missed from work, decreased wages, premature retirement, potentially unemployment, and the medical costs of related illnesses, which may include depression, [...]
The worldwide market for bariatric surgical devices — the surgical device treatment of obesity — is growing at an alarming rate as a result of increasing prevalence in obesity. Data from the World Health Organization and International Obesity Task Force (see report #S825) illustrates how significant both the direct and indirect costs are that are [...]
Specific technologies and broad technology platforms have tremendous potential for market growth based on combinations of recent technology advancement, changes in clinical practice, current forces in the market and other criterial.
Biotech solutions to traditional medical device technologies. The thrust of medical technology is, and has been for a long time, to make it as effective as [...]
The ideal treatment for weight loss is lifestyle modification through diet and exercise: as Aristotle said, “Moderation in all things.” However, the compliance rate for this method of treatment is very low: according to some studies, less than 2% of obese people who lose excess weight through diet and exercise are successful in [...]
Contact:
